ICMR disbands committee formed on research for drug and vaccine

MUMBAI: The Indian Council of Medical Research (ICMR) has disbanded a committee tasked with research for developing a vaccine and drugs to deal with the Covid-19 pandemic, a member of the panel said. No reason was given for the decision by country’s top health body.

The panel was constituted on April 6 and had looked at 100 vaccine candidates and was in the process of identifying new areas of drug and vaccine development.
Debashis Mitra of the National Centre for Cell Science, who was one of the nine members on the committee said, “We got a mail from the chairman (of ICMR) in this regard a few days ago. The panel had met three times in a span of 10 days. However, after the third meeting, the committee was dissolved; we were told that the Department of Biotechnology (DBT) will now look into this.”

The ICMR had formed a task force with five groups on April 6, . These were in the areas of clinical research, research on diagnostics and bio-markers, epidemiology and surveillance, operations research and vaccines/drug research and development. In February, the DBT had formed a group to look at drugs and vaccines research for Covid-19 and had called for proposals from companies.

  • Related Posts

    IPC releases draft NFI-2026 to promote rational use of medicines

    Ghaziabad:- The Indian Pharmacopoeia Commission (IPC) has taken a significant step toward strengthening public health systems with the draft release of the National Formulary of India (NFI) 2026, a comprehensive…

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    An Impacted Denture accidently  had lodged inside it New Delhi: In a remarkable medical achievement, doctors at Sir Ganga Ram Hospital successfully removed an impacted dental plate that had accidentally…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India